IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis

J Cell Mol Med. 2019 Feb;23(2):908-919. doi: 10.1111/jcmm.13992. Epub 2018 Oct 30.

Abstract

Background: Patients with idiopathic pulmonary fibrosis (IPF) often experience acute exacerbation (AE) after an episode of common cold.

Aims: To establish a mouse model of virus infection-induced AE-IPF and investigate the mechanism underlying the AE-IPF.

Methods: Herpes simplex virus 1 (HSV1) was inoculated intranasally to wild-type (WT) and IL-17A gene knockout (IL-17A-/- ) mice 21 days after intratracheal administration of bleomycin (BLM).

Results: HSV1 infection caused acute exacerbation in mice with BLM-induced fibrosis. Compared with the BLM+Saline mice, the mice with BLM+HSV1 showed significantly higher acute lung injury (ALI) score (P < 0.0001), lower survival rate (100% vs 21.4%, P < 0.0001), poorer lung function and higher inflammatory response representing by increased total inflammatory cells in bronchoalveolar lavage fluid (BALF) (P = 0.0323), increased proportion of Th17 cells in peripheral blood (P = 0.0004) and higher inflammatory factors in BALF. In addition, HSV1 infection increased the expression of endoplasmic reticulum stress (ERS)-related proteins in mice with BLM-induced fibrosis. The inhibition of ERS by tauroursodeoxycholic acid (TUDCA, an ERS inhibitor) significantly reduced the IL-17A levels in BALF (P = 0.0140) and TH17 cells in the peripheral blood (P = 0.0084) of mice with BLM+HSV1, suggesting that suppression of ERS may reduce TH17 response in mice with AE-IPF. Compared with WT mice with BLM+HSV1, IL-17A-/- mice with BLM+HSV1 had lower ALI score (P = 0.0119), higher survival rate (78.6% vs 21.4%, P = 0.004), improved lung function, and milder inflammatory response.

Conclusions: HSV1 infection in addition to BLM-induced IPF can successfully establish AE-IPF in mice. IL-17A and ERS promote lung inflammation in AE-IPF development.

Keywords: acute exacerbations of idiopathic pulmonary fibrosis; endoplasmic reticulum stress; herpes simplex virus 1; interleukin-17A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / drug therapy
  • Acute Lung Injury / mortality
  • Acute Lung Injury / virology*
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antiviral Agents / pharmacology
  • Bleomycin
  • Bronchoalveolar Lavage Fluid / chemistry
  • Bronchoalveolar Lavage Fluid / immunology
  • Disease Models, Animal
  • Endoplasmic Reticulum Stress / drug effects
  • Endoplasmic Reticulum Stress / genetics
  • Endoplasmic Reticulum Stress / immunology*
  • Gene Expression
  • Herpes Simplex / chemically induced
  • Herpes Simplex / drug therapy
  • Herpes Simplex / mortality
  • Herpes Simplex / virology*
  • Herpesvirus 1, Human
  • Humans
  • Idiopathic Pulmonary Fibrosis / chemically induced
  • Idiopathic Pulmonary Fibrosis / drug therapy
  • Idiopathic Pulmonary Fibrosis / mortality
  • Idiopathic Pulmonary Fibrosis / virology*
  • Interleukin-17 / deficiency
  • Interleukin-17 / genetics*
  • Interleukin-17 / immunology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Respiratory Function Tests
  • Survival Analysis
  • Taurochenodeoxycholic Acid / pharmacology
  • Th17 Cells / drug effects
  • Th17 Cells / immunology
  • Th17 Cells / virology

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Il17a protein, mouse
  • Interleukin-17
  • Bleomycin
  • Taurochenodeoxycholic Acid
  • ursodoxicoltaurine